You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

47 Results
Guidelines and Advice
Status: Archived
ID: 1-15 Version 3
Version: 3
Sep 2011
Guidelines and Advice
Status: Current
ID: GL-C50-01
Jan 2011
Guidelines and Advice
Nov 2011
Drug
Other Name(s): AMSA P D® (Erfa)
Quick Link(s):
Drug Monograph
Sep 2011
Drug
Other Name(s): Mutamycin® (generic brand available)
Quick Link(s):
Drug Monograph, Patient Info Sheet
May 2018
Drug
Other Name(s): Cytosar® (multiple brands available)
Quick Link(s):
Drug Monograph, Patient Info Sheet
May 2018
Drug
Other Name(s): Novantrone® (multiple brands available)
Quick Link(s):
Drug Monograph, Patient Info Sheet
May 2018
Guidelines and Advice
Status: Current
ID: PET 2017-2
Version: n/a
May 2018
Regimen
Cancer Type:
Hematologic, 
Lymphoma - T-cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Funding:
ODB - General Benefit
    prednisone
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
prednisone,
DOXOrubicin,
vinCRIStine,
cyclophosphamide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2018
Guidelines and Advice
Status: Current
May 2018
Guidelines and Advice
Status: Current
ID: N/A
Version: Final
May 2018

Pages